HomeCompareTYIDF vs PFE

TYIDF vs PFE: Dividend Comparison 2026

TYIDF yields 1.53% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $27.7K in total portfolio value· pulled ahead in Year 9
10 years
TYIDF
TYIDF
● Live price
1.53%
Share price
$127.50
Annual div
$1.95
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.9K
Annual income
$168.66
Full TYIDF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — TYIDF vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTYIDFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TYIDF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TYIDF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TYIDF
Annual income on $10K today (after 15% tax)
$129.85/yr
After 10yr DRIP, annual income (after tax)
$143.36/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,176.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TYIDF + PFE for your $10,000?

TYIDF: 50%PFE: 50%
100% PFE50/50100% TYIDF
Portfolio after 10yr
$35.7K
Annual income
$13,213.69/yr
Blended yield
36.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

TYIDF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.6
Piotroski
8/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TYIDF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTYIDFPFE
Forward yield1.53%6.13%
Annual dividend / share$1.95$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$21.9K$49.6K
Annual income after 10y$168.66$26,258.71
Total dividends collected$1.6K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: TYIDF vs PFE ($10,000, DRIP)

YearTYIDF PortfolioTYIDF Income/yrPFE PortfolioPFE Income/yrGap
1$10,853$152.77$9,153$693.39+$1.7KTYIDF
2$11,767$154.95$8,593$849.25+$3.2KTYIDF
3$12,748$157.02$8,336$1,066.78+$4.4KTYIDF
4$13,799$158.98$8,437$1,384.80+$5.4KTYIDF
5$14,926$160.83$9,013$1,875.40+$5.9KTYIDF
6$16,134$162.58$10,306$2,680.72+$5.8KTYIDF
7$17,427$164.23$12,820$4,101.38+$4.6KTYIDF
8$18,813$165.80$17,673$6,826.70+$1.1KTYIDF
9← crossover$20,297$167.27$27,543$12,591.86$7.2KPFE
10$21,887$168.66$49,560$26,258.71$27.7KPFE

TYIDF vs PFE: Complete Analysis 2026

TYIDFStock

Toyota Industries Corporation manufactures and sells automobiles, material handling equipment, textile machinery, and others in Japan and internationally. The company operates through Automobile, Materials Handling Equipment, and Textile Machinery segments. It provides vehicles; gas, gasoline, and diesel engines for automobiles, industrial equipment, turbochargers, and foundry parts; car air-conditioning compressors; car electronics comprising DC-DC converters, rear inverters, direct-cooling devices, DC-AC inverters, and charging systems; and stamping dies consists of automotive and lift truck stamping dies. The company also offers counterbalanced lift trucks, electric reach trucks, skid steer loaders, tow tractors, and electric tow tractors; stationary/fixed type racks, nesting pallets, mobile racks, and automated storage and retrieval systems; automatic guided vehicle systems, high speed rail guided vehicle systems, and automatic guided lift and pallet trucks. In addition, it provides spinning machines consisting of ring spinning and roving frames; weaving machinery; and cotton classing and yarn testing instruments, as well as leases materials handling systems and industrial equipment. Further, the company offers aerial work platforms; in-house transporters; software; and funding, loan, and other financial services. Additionally, it is involved in the operation of sports facility and nursing homes; real estate leasing; trucking, warehousing, distribution consulting; building management, construction, and real estate; travel agency, renovation, sale of tube amplifiers, and organizing and running of events; personnel placement, contract office staffing, and patent investigation; management and operation of employee clubs and restaurant management; administrative processing for payroll accounting; and contract manufacturing of electronic devices, as well as sale of hardware. The company was incorporated in 1926 and is headquartered in Kariya, Japan.

Full TYIDF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this TYIDF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TYIDF vs SCHDTYIDF vs JEPITYIDF vs OTYIDF vs KOTYIDF vs MAINTYIDF vs JNJTYIDF vs MRKTYIDF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.